HELPING THE OTHERS REALIZE THE ADVANTAGES OF MBL77

mutations and sophisticated kar yotype. It follows a linear evolution with the CLL clone through the recurrent acquisition of CDKN2ANot all clients with CLL need therapy. Regardless of all new advancements, the iwCLL continue to recommends watchful observation for people with asymptomatic sickness.86 This recommendation relies on a minimum of two r